Search

everythinglearnresearchcommunity

for

Search:↓

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hair loss from genetics and hormones can be treated with drugs or surgery.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

MC4R gene variants not linked to female hair loss.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Hair loss led to the diagnosis of Cushing's disease in a patient, showing that hair loss can be a sign of hormonal disorders.

Adjusting estradiol-ANGPT2 levels can promote hair growth in female pattern hair loss.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.